Pre-IPO OrbusNeich Medical Group - The Industry, the Business and the Concerns
472 Views02 Jun 2022 08:28
The rich pipeline and large global business will help OrbusNeich “hedge” negative domestic policy impact. But fierce competition, slow progress in certain fields and other concerns could be challenges
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
Price Chart(Sign Up to Access)
- Pre IPO Shukun Technology - Obvious Strength in Technology/Products but Commercialization Is the Key10 Jun 2022
- Pre-IPO Mega Genomics - Immature Market and Over-Reliance on Meinian Put Future Performance in Doubt09 Jun 2022
- IRay Technology (688301.CH) - Limited Market Space Casts Doubt on Future Growth Potential06 Jun 2022
- Pre-IPO OrbusNeich Medical Group - The Industry, the Business and the Concerns02 Jun 2022
- Venus MedTech (2500.HK) Vs Peijia Medical (9996.HK) Vs CardioFlow (2160.HK) - Dilemma of TAVR Market13 Apr 2022
- Pre-IPO Guanze Intelligent Medical Information Industry - Advantages in Shandong Cannot Hide Worries01 Apr 2022
- Concerns and Outlook on China Neuro-Interventional Industry30 Dec 2021
x